TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 106 filers reported holding TAYSHA GENE THERAPIES INC in Q2 2024. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,298,843 | – | 1,026,269 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 3,333,333 | $9,566,666 | 6.21% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 3,700,000 | $10,619,000 | 1.82% |
| VR Adviser, LLC | 9,000,000 | $25,830,000 | 1.23% |
| Octagon Capital Advisors LP | 3,030,000 | $8,696,100 | 1.04% |
| STEMPOINT CAPITAL LP | 1,087,785 | $3,121,943 | 0.82% |
| RTW INVESTMENTS, LP | 18,593,185 | $53,362,441 | 0.79% |
| Ghost Tree Capital, LLC | 950,000 | $2,726,500 | 0.76% |
| Quantum Private Wealth, LLC | 698,520 | $2,004,753 | 0.74% |
| Avoro Capital Advisors LLC | 18,650,000 | $53,525,500 | 0.62% |
| Sands Capital Ventures, LLC | 724,873 | $2,080,386 | 0.50% |